Medicine
Nafcillin 10 g/100 mL powder for injection
Nafcillin 10 g/100 mL powder for injection is a generic prescription medicine for intravenous use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Before reconstitution store sterile powder at 20º to 25ºC (68º to 77ºF).
Key facts
- Active ingredient (INN)
- Nafcillin
- Brand
- Sold under the generic name
- Strength
- 10 g/100 mL
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 1 vial, 1 bottle and 3 more
- Manufacturers
- EugiaIndiaAvenacyFresenius KabiNorthStar RxSagent Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Before reconstitution store sterile powder at 20º to 25ºC (68º to 77ºF).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01CF06 Nafcillin
- HS code (indicative)
- 3004.10Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 27 April 2011
- Identifiers
- RxCUI 239189DailyMed set ID 91ebf84a-310f-4271-8446-5a10a877883a, 0556378a-b794-4235-ba09-ebdc295e9092, 0f21384c-0f82-4d99-a05c-6773d1ee4bcf +3NDC 72603-567, 83634-101, 55150-124 +2Application ANDA090005, ANDA091614
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, pharmacy bulk package in 1 box / 100 mL in 1 vial, pharmacy bulk package | 55150-124-09 | EugiaIndia | 26 December 2012 |
| 1 vial, pharmacy bulk package in 1 box / 100 mL in 1 vial, pharmacy bulk package | 55150-124-99 | EugiaIndia | 26 December 2012 |
| 1 vial, pharmacy bulk package in 1 carton / 100 mL in 1 vial, pharmacy bulk package | 63323-330-60 | Fresenius Kabi | 27 April 2011 |
| 1 vial in 1 carton / 100 mL in 1 vial | 25021-198-99 | Sagent Pharmaceuticals | 15 April 2025 |
| 1 bottle in 1 carton / 100 mL in 1 bottle | 83634-101-99 | Avenacy | 1 February 2025 |
| 1 vial, pharmacy bulk package in 1 carton / 100 mL in 1 vial, pharmacy bulk package | 72603-567-01 | NorthStar Rx | 1 March 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 11 October 1965 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Nafcillin
Clinical summary
Nafcillin is a penicillin-class antibacterial indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. It is available as powder for injection and injection for intravenous and intramuscular use. MedsAcross supplies Nafcillin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about NafcillinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- NAFCILLIN prescribing information (Baxter Healthcare) · U.S. National Library of Medicine, DailyMed
Need Nafcillin 10 g/100 mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.